Stay updated on Novel Regimens in Relapsed or Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Novel Regimens in Relapsed or Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Novel Regimens in Relapsed or Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe Record History now includes a new revision entry v3.3.4 and removes the previous v3.3.3 entry.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the Record History, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Record History now lists a new revision (Revision: v3.3.2) and removes an earlier one (Revision: v3.2.0). This change affects only the page's version history and does not alter study details or status; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe notice about a lapse in government funding and related operating status details was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check75 days agoChange DetectedThe latest version entry on 2024-10-23 updates the Record History with changes to Study Status and Study Design. This reflects updated details of the trial's status and design on the page.SummaryDifference0.1%

- Check103 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%

Stay in the know with updates to Novel Regimens in Relapsed or Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Regimens in Relapsed or Refractory Multiple Myeloma Clinical Trial page.